Related Experiment Video
Updated: Jun 6, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Contemporary management of coronary heart disease
1Craigavon Cardiac Centre, Craigavon Hospital, Craigavon BT635QQ, Northern Ireland, UK. ian.menown@southerntrust.hscni.net
Insights
This review covers current UK treatments for acute coronary syndromes and stable angina. It details interventions, medications, and lifestyle changes for secondary prevention to reduce heart disease mortality.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Background:
- Coronary heart disease (CHD) is the primary cause of death in the United Kingdom.
- Effective management strategies are crucial for improving patient outcomes and reducing mortality.
Observation:
- Contemporary management of acute coronary syndromes (ACS) and stable angina requires a multifaceted approach.
- Treatment decisions involve evaluating revascularization strategies, such as primary percutaneous coronary intervention versus fibrinolytic therapy.
- Pharmacological interventions, including novel antiplatelet and anticoagulant agents, play a significant role.
Findings:
- The review synthesizes current UK guidelines on managing CHD.
- It highlights the comparative effectiveness of primary percutaneous coronary intervention and fibrinolytic therapy.
- Emerging antiplatelet and anticoagulant therapies offer new treatment avenues.
Implications:
- Optimized secondary prevention and lifestyle modification are essential for long-term CHD management.
- Adherence to updated clinical guidance can significantly impact patient survival rates.
- This review provides a comprehensive overview for healthcare professionals managing CHD patients in the UK.
Abstract:
Coronary heart disease remains the leading cause of mortality in the UK. This review focuses on the contemporary management of patients with acute coronary syndromes and those with stable angina, including the role of primary percutaneous coronary intervention versus fibrinolytic therapy in a UK setting, current and emerging antiplatelet and anticoagulant therapies and the latest guidance on secondary prevention/lifestyle modification.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Angina IV: Management
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Atherosclerosis III: Management